Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Effects of empagliflozin in different phases of diabetes mellitus-related cardiomyopathy: a prospective observational study

Fig. 2

Enrollment and follow-up. Flow diagram shows the recruitment and follow-up process of this study. Abbreviations: CAG, coronary angiography; CMR, cardiac magnetic resonance; DMCMP, diabetes mellitus-related cardiomyopathy; ECV, extracellular volume fraction; LGE, late gadolinium enhancement; LVEF, left ventricular ejection fraction; SGLT2i, sodium-glucose co-transporter 2 inhibitor; T2DM, type 2 diabetes mellitus; UCG, ultrasonic echocardiography

Back to article page